Abstract
Proton pump inhibitors (PPIs) have been demonstrated to prevent gastric mucosal injury by mechanisms independent of acid inhibition. Here we demonstrate that both omeprazole and lansoprazole protect human gastric epithelial and endothelial cells against oxidative stress. This effect was abrogated in the presence of the heme oxygenase-1 (HO-1) inhibitor ZnBG. Exposure to either PPI resulted in a strong induction of HO-1 expression on mRNA and protein level, and led to an increased activity of this enzyme. Expression of cyclooxygenase isoforms 1 and 2 remained unaffected, and COX-inhibitors did not antagonize HO-1 induction by PPIs. Our results suggest that the antioxidant defense protein HO-1 is a target of PPIs in both endothelial and gastric epithelial cells. HO-1 induction might account for the gastroprotective effects of PPIs independently of acid inhibition, especially in NSAID gastropathy. Moreover, our findings provide additional perspectives for a possible but yet unexplored use of PPIs in vasoprotection.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1014-1021 |
| Number of pages | 8 |
| Journal | Biochemical and Biophysical Research Communications |
| Volume | 345 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jul 7 2006 |
Bibliographical note
Funding Information:We thank Professor Dr. H. Matsui, Tsukuba, Japan, who established the RGM-1 rat gastric epithelial cell line, for allowing us to use these cells. The study is supported by a grant of the “Innovative Medical Research Fund” (IMF) of the University of Muenster to JCB (BE 210401). Parts of the study have been demonstrated on DDW Meeting 2005 in Chicago, USA, and are published as an abstract (Gastroenterology 2005; 128, Suppl 2: A 342).
Keywords
- Gastroprotection
- Heme oxygenase-1
- NSAID
- Proton pump inhibitors
- Reactive oxygen species
- Vasoprotection
